The estimated Net Worth of Robert Andrew Douglas is at least $96.1 Million dollars as of 15 August 2023. Mr. Douglas owns over 1,500 units of Resmed stock worth over $63,363,036 and over the last 19 years he sold RMD stock worth over $26,232,103. In addition, he makes $6,490,320 as President und Chief Operating Officer at Resmed.
Sign up
Mr. Douglas RMD stock SEC Form 4 insiders trading
Robert has made over 108 trades of the Resmed stock since 2006, according to the Form 4 filled with the SEC. Most recently he sold 1,500 units of RMD stock worth $271,515 on 15 August 2023.
The largest trade he's ever made was exercising 46,667 units of Resmed stock on 3 August 2012 worth over $1,078,008. On average, Robert trades about 4,615 units every 39 days since 2006. As of 15 August 2023 he still owns at least 250,526 units of Resmed stock.
You can see the complete history of Mr. Douglas stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Douglas biography
Robert Andrew Douglas serves as President, Chief Operating Officer of the Company. He has been ResMed’s president and our chief operating officer. Together with our chief executive officer, he holds full operational responsibility for ResMed and its subsidiaries. Mr. Douglas has had an extensive career within ResMed. His former roles include president – Asia Pacific and chief, global supply operations responsible for global manufacturing and commercial distribution and sales operations in the Asia Pacific region; chief operating officer – Asia Pacific chief operating officer – Sydney responsible for our manufacturing and research and development; vice president of operations responsible for our manufacturing and vice president of respiratory and cardiac business. Mr. Douglas first joined in the role of vice president of corporate marketing. Mr. Douglas has a Master of Business Administration from Macquarie University, a bachelor’s degree in electrical engineering with first-class honors and a B.Sc. (Computer Sciences) from the University of New South Wales, Sydney. Mr. Douglas currently serves as co-vice chairman on the board of directors of the San Diego Regional Economic Development Corporation and is also serving as Vice Chairman of EvoNexus.
What is the salary of Robert Douglas?
As the President und Chief Operating Officer of Resmed, the total compensation of Robert Douglas at Resmed is $6,490,320. There are 1 executives at Resmed getting paid more, with Michael Farrell having the highest compensation of $10,429,800.
How old is Robert Douglas?
Robert Douglas is 60, he's been the President und Chief Operating Officer of Resmed since 2013. There are 9 older and 12 younger executives at Resmed. The oldest executive at Resmed Inc. is Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD, 79, who is the Founder & Non-Exec. Chairman.
What's Robert Douglas's mailing address?
Robert's mailing address filed with the SEC is VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403.
Insiders trading at Resmed
Over the last 23 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace und David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.
What does Resmed do?
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
What does Resmed's logo look like?
Complete history of Mr. Douglas stock trades at Globus Medical Inc und Resmed
Resmed executives and stock owners
Resmed executives and other stock owners filed with the SEC include:
-
Michael Farrell,
Chief Executive Officer, Director -
Robert Douglas,
President, Chief Operating Officer -
Jim Hollingshead,
President – sleep and respiratory care business -
Rajwant Sodhi,
President – Software as a Service Business (SaaS) -
Brett Sandercock,
Chief Financial Officer -
Michael J. Farrell BE, SM, MBA,
CEO & Director -
David Pendarvis,
Chief Administrative Officer, Global General Counsel, Secretary -
Michael J. Farrell BE, MBA, SM,
CEO & Director -
Robert A. Douglas,
Pres & COO -
Dr. James R. Hollingshead Ph.D.,
Pres of Sleep & Respiratory Care Bus. -
Brett A. Sandercock,
Chief Financial Officer -
Peter Farrell,
Non-Executive Chairman of the Board -
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD,
Founder & Non-Exec. Chairman -
Dr. Peter C. Farrell A.M., B.E., Ph.D., BE (Hons), ScD, AM,
Founder & Non-Exec. Chairman -
Ronald Taylor,
Lead Independent Director -
Carol Burt,
Independent Director -
Richard Sulpizio,
Independent Director -
Harjit Gill,
Independent Director -
Jan De Witte,
Independent Director -
Karen Drexler,
Independent Director -
Justin Leong,
President – Asia and Latin America -
Urvashi Tyagi,
Chief Technology Officer -
Nupur Bhushan,
Chief People Officer -
David B. Pendarvis,
Chief Admin. Officer, Global Gen. Counsel & Corp. Sec. -
Amy Wakeham,
VP of Investor Relations & Corp. Communications -
Constance C. Bienfait,
Director of Investor Relations -
Kaushik Ghoshal,
Pres of SaaS Bus. & CTO -
John P Wareham,
Director -
Christopher G Roberts,
Director -
Donald Darkin,
Sr. Vice President, Pat Inter -
Gary W Pace,
Director -
Anne Reiser,
President - ResMed Europe -
Richard Mc Hale,
President, RC Business -
Inc Resmed,
Director -
James Hollingshead,
President, Sleep Business -
Kieran Gallahue,
President, Global -
Paul Eisen,
Vice President, Europe & Asia -
Donagh Mccarthy,
Director -
Adrian M Smith,
CFO -
Klaus H Shindhelm,
Sr. Vice President, Operations -
Keith Serzen,
Chief Operating Officer -
Louis A Simpson,
Director -
Christopher Bartlett,
Director -
Walter Flicker,
VP and Asst. Corp. Secretary -
Lasse Beijer,
COO-Europe -
Stein Jacobsen,
COO, Europe -
Michael A Quinn,
Director -
Kaushik Ghoshal,
President, SaaS Business -
Lucile Blaise,
President, Sleep & RC Business -
John Hernandez,
Director -
Desney Tan,
Director -
Michael J Rider,
Global General Counsel -
Christopher Del Orefice,
Director